Table 1.
Laboratory data on admission
| CBC | Serum chemistry | Tumor marker | Urinary data | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WBC |
5960 |
/μl |
TP |
6.1 |
g/dl |
sIL-2R |
702.3 |
(206–713)* |
U/ml |
SG |
1.002 |
|
| Neut |
53.4 |
% |
Alb |
3.8 |
g/dl |
CYFRA |
2 |
(< 3.5)* |
ng/ml |
Osmolality |
178 |
mOsm/kg/H2O |
| Lym |
36.9 |
% |
BUN |
14 |
mg/dl |
ProGRP |
49.9 |
(< 81)* |
pg/ml |
Na |
18 |
mmol/l |
| Mo |
8.2 |
% |
Cre |
0.88 |
mg/dl |
CEA |
1.3 |
(< 5.0)* |
ng/ml |
Volume |
5475 |
ml/day |
| Eo |
1.2 |
% |
UA |
3.9 |
mg/dl |
|
|
|
|
|
|
|
| Ba |
0.3 |
% |
T-bil |
0.8 |
mg/dl |
Endocrinology (basal hormone levels) |
|
|
|
|||
| RBC |
363×104 |
/μl |
D-bil |
0.4 |
mg/dl |
GH |
0.4 |
(< 2.47)* |
ng/ml |
|
|
|
|
Hb |
11.9 |
g/dl |
AST |
13 |
U/l |
PRL |
20.9 |
(4.29-13.69)* |
ng/ml |
|
|
|
| Plt |
18.4×104 |
/μl |
ALT |
16 |
U/l |
LH |
0.2 |
(0.79-5.72)* |
mU/ml |
|
|
|
| |
|
|
ALP |
175 |
U/l |
FSH |
1 |
(2.00-8.30)* |
mU/ml |
|
|
|
|
Coagulation |
|
|
γ-GTP |
20 |
U/l |
ACTH |
2 |
(7.2-63.3)* |
pg/ml |
|
|
|
| PT % |
111 |
% |
LDH |
230 |
U/l |
Cortisol |
2.4 |
(4.0-18.3)* |
mg/dl |
|
|
|
| APTT |
29.9 |
sec |
Na |
139 |
mmol/l |
IGF-1 |
105 |
(75–226)* |
ng/ml |
|
|
|
| Fib |
255 |
mg/dl |
K |
3.8 |
mmol/l |
TSH |
0.04 |
(0.5-5.0)* |
μU/ml |
|
|
|
| D-Dimer |
0.9 |
μg/ml |
Cl |
100 |
mmol/l |
f-T4 |
0.86 |
(0.90-1.70)* |
ng/dl |
|
|
|
| |
|
|
Ca |
8.7 |
mg/dl |
ADH |
0.5 |
(0.3-3.5)* |
pg/ml |
|
|
|
|
Infection |
|
|
CK |
19 |
U/l |
Testosterone |
< 0.02 |
(1.31-8.71)* |
ng/ml |
|
|
|
|
QFT |
(+) |
|
CRP |
0.06 |
mg/dl |
DHEA-EIA |
7 |
(24–244)* |
μg/dl |
|
|
|
| |
|
|
Osmolality |
288 |
mOsm/kg/H2O |
Aldosterone |
11.4 |
(35.7-240)* |
pg/ml |
|
|
|
| Renin activity | 0.7 | (0.3-2.9)* | ng/ml/hr | |||||||||
*reference data.
QFT QuantiFERON TB2G.
SG specific gravity.
Pathologic parameters were underlined.